The CEO of an Australian IT startup has designed a personalized cancer vaccine for his dog diagnosed with a terminal illness using artificial intelligence (AI) and confirmed its therapeutic effects.

The company’s cash and securities nearly equal its market value, meaning investors aren’t paying much for the Covid franchise ...

Immunis Inc. has struck a licensing deal with Japanese material manufacturer Toray Industries Inc. to develop a potential ...